Info
diagnostic evaluation of primary myelofibrosis (PMF)
(Blood 2010;115:1703 & 2016;127:2391)
- Anemia with variable WBC and platelet counts
Peripheral smear
→ “leukoerythroblastic” (teardrop cells, nucleated RBCs, immature WBCs); large abnormal platelets
BM aspirate
→ “dry” tap; BM bx → severe fibrosis, replacement by reticulin & collagen
Mutation
- JAK2 V617F in 45–50%
- CALR mut in 45–50%,
- MPL mut in 7–10%,
- triple neg in 1–2%
-
No BCR-ABL translocation; Pts should not meet criteria for PV or MDS
-
DIPSS score for prognosis. High-risk factors: age >65, WBC >25k, Hgb <10, peripheral blasts >1%, symptoms, complex cytogenetics, absence of CALR type 1.